Delivery Order SPE2DR25D1100-SPE2DR26FCV8K
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,058.12 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packaging. This competitive award, issued on November 26, 2025, with completion targeted for November 28, 2025, employs firm fixed pricing with no set-aside designation. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and headquarters....
- The Defense Logistics Agency awarded a $13,166.75 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packages of three. The contract, which is unset-aside and competitively awarded, is scheduled for completion by December 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $3,976.38 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 5 mg orally disintegrating tablets (ODT) in unit doses of three tablets per package. This contract represents a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The award was issued on September 22, 2025, with an ultimate completion date of September 23, 2025, and the product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $2,597.90 to AmerisourceBergen Drug Corp for Zolmitriptan 5 mg orally disintegrating tablets in unit dose packaging of three units. This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of December 12, 2025. The award was issued on December 11, 2025, and the pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packaging. This competitive award, valued at $1,613.03 with a firm fixed price structure, represents a single delivery order without set-aside designation. The contract is scheduled for completion on October 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,215.11 to AmerisourceBergen Drug Corp for Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packages of six on August 11, 2025. This firm fixed price delivery order, which is expected to be completed by August 12, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,776.11 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 2.5 mg oral disintegrating tablets in unit dose packaging. This non-competitive, firm fixed-price delivery order was executed on December 11, 2025, with an ultimate completion date of December 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packaging. This competitively awarded, non-set-aside contract carries a ceiling value of $1,069.34 and is classified as a firm fixed price delivery order with an ultimate completion date of November 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packages of three. This is a firm fixed-price delivery order with a ceiling value of $33,895.75 and an ultimate completion date of December 17, 2025. The award was made without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,257.26 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packaging (6 tablets). This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 22, 2025, and represents a non-set-aside procurement. The pharmaceutical will be delivered to the Conshohocken, Pennsylvania location of AmerisourceBergen Drug Corp, the nation's largest...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCV8KDelivery Order
The Defense Logistics Agency (DLA) awarded a $3,117.48 delivery order to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packs of three. This contract is a firm fixed-price award with no set-aside designation, issued on December 19, 2025, with an ultimate completion date of December 22, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's existing contract vehicles with DLA. This award is issued as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying an extensive portfolio of brand-name and generic medications across multiple therapeutic domains. The company has demonstrated consistent capability to meet federal procurement requirements through competitive awards with DLA, supporting Defense Health Agency operations and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 12/18/25 |